Stocks · Healthcare · Medical - Devices
AdaptHealth Corp. AHCO
$5.74 +2.50% Close, Oct 5, 2026 · NASDAQ · Market cap $761.9M
Weak trendInexpensive vs sector
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-1.68, down 411.1% year over year.
- Operating margin narrowed to -0.3% from 10.0% a year earlier.
- Net debt is 7.0× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 40%
- EPS growth (TTM, YoY)Bottom 7%
- FCF growth (TTM, YoY)Bottom 16%
- Revenue growth, 3-year CAGRBottom 32%
- Revenue growth accelerationTop 17%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 32%
- Gross marginBottom 10%
- Operating marginTop 42%
- Accruals (lower is better)Top 16%
- Net debt / EBITDA (lower is better)Bottom 10%
- Interest coverTop 44%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 24%
- Free-cash-flow yieldTop 4%
- EBITDA / enterprise valueTop 9%
- Sales / enterprise valueTop 8%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 16%
- 6-month returnBottom 4%
- 1-year return vs S&P 500Bottom 15%
- Distance from 52-week highBottom 19%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetTop 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 6%
- Maximum drawdown, 3 yearsTop 36%
- Beta vs S&P 500 (lower is better)Top 2%
- Net debt / EBITDA (lower is better)Bottom 10%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.8% | 14.6% | ↑ |
| EPS growth (YoY) | -203.5% | -411.1% | ↓ |
| Gross margin | 4.3% | 10.4% | ↑ |
| Operating margin | 10.0% | -0.3% | ↓ |
| FCF margin | 8.8% | 3.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 14.6% | 8.8% | ↑ | Top 40% |
| EPS growth (TTM, YoY) | -411.1% | -203.5% | ↓ | Bottom 7% |
| Gross margin | 10.4% | 4.3% | ↑ | Bottom 10% |
| Operating margin | -0.3% | 10.0% | ↓ | Top 42% |
| Net margin | -7.6% | 3.1% | ↓ | — |
| Free-cash-flow margin | 3.2% | 8.8% | ↓ | — |
| Return on invested capital | -0.2% | — | Top 32% | |
| Revenue growth, 3-year CAGR | 3.0% | — | Bottom 32% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -18.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -15.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 6.97×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.21%
- Shareholder yield
- -0.21%
- Share count change, 1 year
- -0.7%
- Share count change, 3-year CAGR
- -0.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -2.1%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $9.83
- Target vs current price
- +71.3%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -64.5% | -38.0% | -51.8% | -48.4% | — |
| May 5, 2026 | -580.0% | -9.9% | -13.8% | -26.0% | -18.1% |
| Feb 24, 2026 | -20.6% | -13.9% | -6.3% | +0.8% | +0.6% |
| Nov 4, 2025 | -8.3% | +17.4% | +3.4% | +3.7% | +10.6% |
| Aug 5, 2025 | -93.3% | +11.0% | +2.4% | +0.4% | +4.0% |
| May 6, 2025 | +0.0% | +1.7% | +4.7% | +1.8% | +3.1% |
| Feb 25, 2025 | +56.0% | +24.4% | +28.7% | +21.5% | +8.2% |
| Nov 5, 2024 | -11.8% | -9.6% | +3.0% | -5.6% | +0.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.06 | $0.17 | -64.5% | $740.3M |
| May 5, 2026 | -$0.06 | $0.01 | -580.0% | $819.8M |
| Feb 24, 2026 | $0.27 | $0.34 | -20.6% | $846.3M |
| Nov 4, 2025 | $0.22 | $0.24 | -8.3% | $820.3M |
| Aug 5, 2025 | $0.01 | $0.15 | -93.3% | $800.4M |
| May 6, 2025 | $0.01 | $0.01 | +0.0% | $777.9M |
| Feb 25, 2025 | $0.39 | $0.25 | +56.0% | $856.6M |
| Nov 5, 2024 | $0.15 | $0.17 | -11.8% | $805.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 9.6× | — | — | Top 9% |
| EV / Sales | 0.93× | — | — | Top 8% |
| Free-cash-flow yield | 12.82% | — | — | Top 4% |
| Earnings yield | -29.27% | — | — | Bottom 24% |
P/E over the past five years
Range 15.5× – 122.3× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -39.2%
- Earnings per share growth (TTM)
- -411.1%
- Change in P/E multiple
- -84.1%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -22.9%
- 200-day average slope (20 days)
- -3.9%
- Distance from 50-day average
- -10.4%
- Distance from 200-day average
- -40.1%
- RSI (14)
- 44.1
- Relative volume
- 1.24×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 111.8%
- Volatility vs own 5-year history
- 99th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.09
- Correlation with S&P 500
- -0.02
- Current drawdown from 1-year high
- -57.1%
- Maximum drawdown, 3 years
- -61.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 1, 2021 | Aug 10, 2026 | -87.0% | 1386 days | Not yet recovered |
| Dec 22, 2020 | Jan 5, 2021 | -12.0% | 8 days | 18 days (Feb 1, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $761.9M
- EPS, diluted (TTM)
- -$1.68
- Revenue (TTM)
- $3.01B
- 52-week range
- $5.21 – $13.43
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.45B | $2.97B | $3.20B | $3.26B | $3.24B |
| Gross profit | $445.6M | $417.4M | $681.8M | $681.1M | $568.6M |
| Operating income | $225.6M | $190.4M | -$598.4M | $263.7M | $186.3M |
| Net income | $156.2M | $69.3M | -$678.9M | $90.4M | -$70.8M |
| EPS (diluted) | $0.67 | $0.50 | -$5.31 | $0.61 | -$0.52 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $597.5M | $856.6M | $580.5M | $591.8M | $602.6M | $846.3M | $819.8M | $740.3M |
| Net income | $22.9M | $50.3M | -$7.2M | $14.7M | $24.5M | -$102.8M | -$16.0M | -$133.9M |
| EPS (diluted) | $0.15 | $0.34 | -$0.05 | $0.10 | $0.16 | -$0.73 | -$0.12 | -$0.99 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $275.7M | $373.9M | $480.7M | $541.8M | $601.8M |
| Capital expenditure | -$203.3M | -$391.4M | -$337.5M | -$306.1M | -$382.4M |
| Free cash flow | $72.4M | -$17.6M | $143.2M | $235.8M | $219.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $278.9M | -$14.0M | -$29.3M | $0 | $1.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $43.3M
- Total assets
- $4.34B
- Total liabilities
- $2.95B
- Total debt
- $2.07B
- Net debt
- $2.02B
- Shareholders’ equity
- $1.38B
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 9,633,037
- Days to cover
- 3.15
- Change vs previous report
- -7.3%
FINRA short interest, settlement date Sep 15, 2026.